vs

Side-by-side financial comparison of BIOHARVEST SCIENCES INC. (BHST) and enCore Energy Corp. (EU). Click either name above to swap in a different company.

enCore Energy Corp. is the larger business by last-quarter revenue ($12.4M vs $8.4M, roughly 1.5× BIOHARVEST SCIENCES INC.).

BioHarvest Sciences Inc. is a biotechnology firm that develops and produces sustainable, high-purity plant-derived bioactive ingredients. It serves the nutraceutical, cosmetics, and pharmaceutical sectors, leveraging proprietary cell cultivation technology to create efficacious natural products without large-scale agricultural farming.

Devon Energy Corporation is an American company engaged in hydrocarbon exploration. It is organized in Delaware with operational headquarters in the 50-story Devon Energy Center in Oklahoma City, Oklahoma. Its operations are in the Delaware Basin, Eagle Ford Group, and the Rocky Mountains.

BHST vs EU — Head-to-Head

Bigger by revenue
EU
EU
1.5× larger
EU
$12.4M
$8.4M
BHST

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
BHST
BHST
EU
EU
Revenue
$8.4M
$12.4M
Net Profit
$-21.5M
Gross Margin
60.3%
37.9%
Operating Margin
-135.9%
Net Margin
-173.9%
Revenue YoY
Net Profit YoY
EPS (diluted)
$-0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BHST
BHST
EU
EU
Q4 25
$12.4M
Q3 25
$8.4M
$8.9M
Q2 25
$8.1M
$3.7M
Q1 25
$7.7M
$18.2M
Q3 24
$6.5M
Q2 24
$6.0M
Net Profit
BHST
BHST
EU
EU
Q4 25
$-21.5M
Q3 25
$-4.8M
Q2 25
$-6.3M
Q1 25
$-24.2M
Q3 24
Q2 24
Gross Margin
BHST
BHST
EU
EU
Q4 25
37.9%
Q3 25
60.3%
43.8%
Q2 25
60.0%
30.8%
Q1 25
58.2%
-0.1%
Q3 24
Q2 24
Operating Margin
BHST
BHST
EU
EU
Q4 25
-135.9%
Q3 25
-158.2%
Q2 25
-526.1%
Q1 25
-85.7%
Q3 24
Q2 24
Net Margin
BHST
BHST
EU
EU
Q4 25
-173.9%
Q3 25
-53.7%
Q2 25
-172.7%
Q1 25
-132.9%
Q3 24
Q2 24
EPS (diluted)
BHST
BHST
EU
EU
Q4 25
$-0.11
Q3 25
$-0.03
Q2 25
$-0.03
Q1 25
$-0.13
Q3 24
Q2 24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BHST
BHST
EU
EU
Cash + ST InvestmentsLiquidity on hand
$52.4M
Total DebtLower is stronger
$110.0M
Stockholders' EquityBook value
$229.2M
Total Assets
$430.4M
Debt / EquityLower = less leverage
0.48×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BHST
BHST
EU
EU
Q4 25
$52.4M
Q3 25
$91.9M
Q2 25
$26.9M
Q1 25
$29.7M
Q3 24
Q2 24
Total Debt
BHST
BHST
EU
EU
Q4 25
$110.0M
Q3 25
$109.3M
Q2 25
Q1 25
Q3 24
Q2 24
Stockholders' Equity
BHST
BHST
EU
EU
Q4 25
$229.2M
Q3 25
$248.6M
Q2 25
$264.7M
Q1 25
$267.9M
Q3 24
Q2 24
Total Assets
BHST
BHST
EU
EU
Q4 25
$430.4M
Q3 25
$441.9M
Q2 25
$359.4M
Q1 25
$362.6M
Q3 24
Q2 24
Debt / Equity
BHST
BHST
EU
EU
Q4 25
0.48×
Q3 25
0.44×
Q2 25
Q1 25
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BHST
BHST
EU
EU
Operating Cash FlowLast quarter
$12.9M
Free Cash FlowOCF − Capex
$7.2M
FCF MarginFCF / Revenue
57.8%
Capex IntensityCapex / Revenue
46.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-45.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BHST
BHST
EU
EU
Q4 25
$12.9M
Q3 25
$-20.3M
Q2 25
$-9.9M
Q1 25
$-7.7M
Q3 24
Q2 24
Free Cash Flow
BHST
BHST
EU
EU
Q4 25
$7.2M
Q3 25
$-26.3M
Q2 25
$-14.1M
Q1 25
$-11.7M
Q3 24
Q2 24
FCF Margin
BHST
BHST
EU
EU
Q4 25
57.8%
Q3 25
-296.6%
Q2 25
-385.2%
Q1 25
-64.1%
Q3 24
Q2 24
Capex Intensity
BHST
BHST
EU
EU
Q4 25
46.7%
Q3 25
68.0%
Q2 25
115.1%
Q1 25
21.7%
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons